Growth factors produced by sarcoma virus-transformed cells.
about
Complexities of TGF-β targeted cancer therapy.Effects of in vivo-administered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, mouse, and hamsterA central theory of biologyMechanism of tumor promoter inhibition of cellular binding of epidermal growth factorInvolvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation.Differences in mechanisms of transformation by independent feline sarcoma virus isolates.Anchorage-independent growth of normal human fibroblasts.Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia.Similarities and differences between the effects of epidermal growth factor and Rous sarcoma virus.An agent or agents produced by virus-transformed cells cause unregulated ruffling in untransformed cells.Cell-mediated co-action of transforming growth factors: incubation of type beta with normal rat kidney cells produces a soluble activity that prolongs the ruffling response to type alphaEpidermal growth factor and insulin cause normal chicken heart mesenchymal cells to proliferate like their Rous sarcoma virus-infected counterpartsIdentification of tryptic peptides unique to a 110,000-molecular weight polyprotein encoded by the T-8 isolate of murine leukemia virusTransforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors.Suppression of proline-directed protein kinase F(A) expression inhibits the growth of human chronic myeloid leukaemia cells.Increased secretion of type beta transforming growth factor accompanies viral transformation of cellsVaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.Epidermal growth factor receptor metabolism and protein kinase activity in human A431 cells infected with Snyder-Theilen feline sarcoma virus or harvey or Kirsten murine sarcoma virus.Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesotheliomaThe activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cellsAutocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.The Molecular Apgar Score: A Key to Unlocking Evolutionary PrinciplesMutual regulation of the Hippo/Wnt/LPA/TGF‑β signaling pathways and their roles in glaucoma (Review).
P2860
Q27693607-7142F8DC-5795-4433-B0B7-26A22D235262Q28646019-AF9C6D98-3A62-4F7C-ACE4-905E264C235AQ28646894-50DB02CA-EEF6-4401-B683-D2B9828B9B08Q34037558-5ADBC529-2F5A-4E32-96D1-B6CF09234601Q35235830-49AF73C8-DB7D-495E-AE09-A7C535691209Q35238748-FBCC9A18-6011-43C4-A376-5427328C0A55Q35363420-CB716BB6-B9AB-4A05-BE4E-8785C604D69EQ35381265-669B28D4-2D7B-459B-B62F-07FF3F95BE1DQ36208799-4EAEB00A-BA3C-4525-9AC6-95B417453B3DQ36214782-05ADD5AD-B217-42F6-89F7-E8C35C612236Q36214857-E248CFD3-774D-4E42-80A8-686676C35956Q36282407-FA4565A9-A889-4FD0-AEF0-C4A37B921521Q36344307-736EB0FE-64F1-493B-9BCB-DD858817C581Q36405679-1904B112-8E71-4DDC-9A73-1829BDDBD984Q36621373-7F5B1E31-9FD4-42C4-8272-BCE760F65E39Q36885110-3B9D695A-416E-4553-94C1-25B02E71AF50Q36909038-17834CB3-84B8-4120-8237-0410E7C054D1Q36910342-38C5B683-5BDA-4FCB-9127-D7012FBE6048Q37025320-6EA13FD3-CCE1-4A31-9508-112CFF97181AQ37349044-EF6AE7F4-7913-4C75-869A-5651361EC236Q37617811-0ACACE0C-8DF2-4531-83A8-39D56FDF8AE1Q39290976-4A06DCA2-C3F5-4711-B59B-757C781F4C2DQ41341172-BA562E9C-48BC-4869-A33D-0E33CAE58DECQ41609616-A4527234-868A-4697-9977-4ED852A7795DQ42132569-7A65FC3E-3030-455C-8E9F-5CE7E08262C6Q42315412-616903DF-AA39-4F7E-9EC1-B74C6CE56C84Q47212698-6DFFF49C-3AB8-4E53-B6E2-FD30517D589B
P2860
Growth factors produced by sarcoma virus-transformed cells.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Growth factors produced by sarcoma virus-transformed cells.
@en
type
label
Growth factors produced by sarcoma virus-transformed cells.
@en
prefLabel
Growth factors produced by sarcoma virus-transformed cells.
@en
P1433
P1476
Growth factors produced by sarcoma virus-transformed cells.
@en
P2093
De Larco JE
P304
P407
P433
P577
1978-11-01T00:00:00Z